ARCB
Q4 2026 EPS Estimate
$2.34
Nov 4, 2026 · Reports before open
Revenue Estimate
$1.19B
FY2026E EPS$6.79
FY2027E EPS$9.49

Analyst Sentiment

Wall St. Consensus
Hold
21 analysts·High coverage
62
Score
11 Buy (52%)9 Hold (43%)1 Sell (5%)
Rating Breakdown
Strong Buy
00%
Buy
1152%
Hold
943%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$145.00
+4.3%
Consensus
$163.00
+17.2%
Bull
$180.00
+29.4%
12-Month Target Range21 analysts
$145.00$163.00$180.00
Current $139.07Consensus
Current Price
$139.07
Upside to Consensus
$23.93

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+7.78%
EPS+39.71%
FY2028
Rev+7.44%
EPS+24.89%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$4.49B$4.83B$5.19B
Low$4.45B$4.67B$4.92B
High$4.54B$4.99B$5.57B
EBITDA Avg$402M$433M$466M
Low$398M$418M$441M
High$406M$447M$499M
EBIT Avg$248M$267M$287M
Low$246M$258M$272M
High$251M$276M$308M
Net Income Avg$153M$204M$272M
Low$151M$198M$260M
High$167M$240M$284M
EPS Avg$6.79$9.49$11.85
Low$6.59$8.64$11.33
High$7.29$10.45$12.36
Analysts (Rev / EPS)9 / 89 / 88 / 2
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$1.19B$1.11B$1.09B$1.25B$1.26B$1.17B$1.25B$1.26B
Low$1.15B$1.05B$1.05B$1.20B$1.22B$1.13B$1.20B$1.21B
High$1.24B$1.17B$1.14B$1.30B$1.31B$1.22B$1.30B$1.31B
EBITDA Avg$107M$99M$98M$112M$113M$105M$112M$113M
Low$103M$94M$94M$108M$109M$101M$108M$108M
High$111M$105M$102M$117M$118M$109M$116M$117M
EBIT Avg$66M$61M$60M$69M$70M$65M$69M$69M
Low$64M$58M$58M$67M$67M$63M$66M$67M
High$68M$64M$63M$72M$73M$67M$72M$72M
Net Income Avg$52M$39M$27M$63M$66M$54M$28M$81M
Low$50M$35M$26M$60M$63M$52M$27M$77M
High$55M$45M$29M$67M$70M$57M$30M$85M
EPS Avg$2.34$1.75$1.22$2.83$2.97$2.43$1.27$3.61
Low$2.24$1.59$1.16$2.70$2.83$2.32$1.21$3.44
High$2.47$2.02$1.28$2.98$3.13$2.56$1.34$3.80
Analysts (Rev / EPS)7 / 97 / 83 / 33 / 43 / 36 / 45 / 44 / 5

Earnings Surprises

Recent Analyst Actions

Aug 3, 2026UBS
ArcBest price target raised to $154 from $145 at UBS
Target:$154.00
+6.7%from $144.35
Jul 29, 2026Goldman Sachs
ArcBest price target raised to $172 from $165 at Goldman Sachs
Target:$172.00
+21.6%from $141.49
Jul 21, 2026Stifel Nicolaus
ArcBest price target raised to $176 from $134 at Stifel
Target:$176.00
+11.3%from $158.20
Jul 7, 2026UBS
ArcBest price target raised to $145 from $122 at UBS
Target:$145.00
+2.6%from $141.29
Jul 6, 2026Morgan Stanley
ArcBest price target raised to $180 from $150 at Morgan Stanley
Target:$180.00
+28.9%from $139.67
Jun 23, 2026Goldman Sachs
ArcBest price target raised to $165 from $117 at Goldman Sachs
Target:$165.00
+13.3%from $145.60
Jun 5, 2026Wells Fargo
ArcBest price target raised to $150 from $130 at Wells Fargo
Target:$150.00
+2.7%from $146.08
Apr 29, 2026Truist Financial
ArcBest price target raised to $145 from $95 at Truist
Target:$145.00
+10.2%from $131.55
Apr 29, 2026Morgan Stanley
ArcBest price target raised to $150 from $120 at Morgan Stanley
Target:$150.00
+17.4%from $127.76
Apr 29, 2026UBS
ArcBest price target raised to $122 from $98 at UBS
Target:$122.00
-4.5%from $127.76
Apr 28, 2026Goldman Sachs
ArcBest price target raised to $117 from $102 at Goldman Sachs
Target:$117.00
-8.4%from $127.76
Apr 16, 2026Stifel Nicolaus
ArcBest price target raised to $116 from $94 at Stifel
Target:$116.00
+7.2%from $108.19
Feb 4, 2026UBS
ArcBest price target raised to $98 from $77 at UBS
Target:$98.00
-9.5%from $108.28
Feb 2, 2026Stifel Nicolaus
ArcBest price target lowered to $94 from $96 at Stifel
Target:$94.00
+4.2%from $90.22
Feb 1, 2026Wells Fargo
ArcBest price target raised to $85 from $74 at Wells Fargo
Target:$85.00
-5.8%from $90.22
Jan 31, 2026Goldman Sachs
ArcBest price target raised to $100 from $91 at Goldman Sachs
Target:$100.00
+10.8%from $90.22
Jan 21, 2026Stifel Nicolaus
ArcBest price target raised to $96 from $85 at Stifel
Target:$96.00
+11.3%from $86.29
Jan 15, 2026Truist Financial
ArcBest price target raised to $95 from $85 at Truist
Target:$95.00
+4.2%from $91.15
Jan 6, 2026Stephens
ArcBest price target raised to $85 from $72 at Stephens
Target:$85.00
+4.0%from $81.72
Oct 28, 2025Stifel Nicolaus
ArcBest price target raised to $85 from $81 at Stifel
Target:$85.00
+13.8%from $74.67
Sep 30, 2025UBS
ArcBest price target raised to $80 from $73 at UBS
Target:$80.00
+15.3%from $69.41
Jul 31, 2025Stifel Nicolaus
ArcBest Corp (ARCB) PT Lowered to $81 at Stifel
Target:$81.00
+11.7%from $72.51
Feb 3, 2025Morgan Stanley
ArcBest price target lowered to $145 from $160 at Morgan Stanley
Target:$145.00
+58.6%from $91.40
Oct 9, 2024Citigroup
This Chewy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Target:$111.00
+8.6%from $102.19
Aug 6, 2024Stifel Nicolaus
ArcBest Corp (ARCB) PT Lowered to $131 at Stifel
Target:$131.00
+19.9%from $109.22
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.